Data Patterns (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:15 pm

Quick Insight

Data Patterns (India) Ltd, operating in the Aerospace & Defense industry, demonstrates strong financial indicators with a P/E ratio of 65.4, ROE at 15.2%, and ROCE at 21.0%. The company's OPM stands at an impressive 32%, reflecting efficient operational management. With Net Profit of 222Cr and Reserves totaling 1,497Cr, Data Patterns shows stability and growth potential. However, the high P/BV ratio of 6.28x suggests the stock may be overvalued, while the CCC of 618 days indicates a need to manage cash conversion cycles effectively. Investors should closely monitor these metrics to make informed decisions in this sector.

Competitors of Data Patterns (India) Ltd

All Competitor Stocks of Data Patterns (India) Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:25 pm

Below is a detailed analysis of the quarterly data for Data Patterns (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 396.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 297.00 Cr..
• For Expenses, as of Jun 2025, the value is 67.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 247.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 180.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 117.00 Cr..
• For OPM %, as of Jun 2025, the value is 32.00%. The value appears to be declining and may need further review. It has decreased from 38.00% (Mar 2025) to 32.00%, marking a decrease of 6.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 153.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 119.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 114.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 88.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.55. The value appears to be declining and may need further review. It has decreased from 20.38 (Mar 2025) to 4.55, marking a decrease of 15.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:59 pm

Balance Sheet

Last Updated: July 25, 2025, 1:29 pm

Below is a detailed analysis of the balance sheet data for Data Patterns (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,497.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,313.00 Cr. (Mar 2024) to 1,497.00 Cr., marking an increase of 184.00 Cr..
• For Borrowings, as of Mar 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 325.00 Cr.. The value appears to be improving (decreasing). It has decreased from 364.00 Cr. (Mar 2024) to 325.00 Cr., marking a decrease of 39.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,839.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,692.00 Cr. (Mar 2024) to 1,839.00 Cr., marking an increase of 147.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 150.00 Cr. (Mar 2024) to 247.00 Cr., marking an increase of 97.00 Cr..
• For CWIP, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 48.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 327.00 Cr.. The value appears strong and on an upward trend. It has increased from 262.00 Cr. (Mar 2024) to 327.00 Cr., marking an increase of 65.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,231.00 Cr. (Mar 2024) to 1,216.00 Cr., marking a decrease of 15.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,839.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,692.00 Cr. (Mar 2024) to 1,839.00 Cr., marking an increase of 147.00 Cr..

Notably, the Reserves (1,497.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Data Patterns (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 39.62. This value is within the healthy range. It has increased from 32.45 (Mar 24) to 39.62, marking an increase of 7.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 39.62. This value is within the healthy range. It has increased from 32.45 (Mar 24) to 39.62, marking an increase of 7.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.09. This value is within the healthy range. It has increased from 35.33 (Mar 24) to 42.09, marking an increase of 6.76.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.32. It has increased from 236.47 (Mar 24) to 269.32, marking an increase of 32.85.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.32. It has increased from 236.47 (Mar 24) to 269.32, marking an increase of 32.85.
• For Dividend / Share (Rs.), as of Mar 25, the value is 7.90. This value exceeds the healthy maximum of 3. It has increased from 6.50 (Mar 24) to 7.90, marking an increase of 1.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 126.49. It has increased from 92.82 (Mar 24) to 126.49, marking an increase of 33.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 57.38. This value is within the healthy range. It has increased from 47.79 (Mar 24) to 57.38, marking an increase of 9.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is 54.90. This value is within the healthy range. It has increased from 44.91 (Mar 24) to 54.90, marking an increase of 9.99.
• For PBT / Share (Rs.), as of Mar 25, the value is 52.74. This value is within the healthy range. It has increased from 43.25 (Mar 24) to 52.74, marking an increase of 9.49.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 39.61. This value is within the healthy range. It has increased from 32.44 (Mar 24) to 39.61, marking an increase of 7.17.
• For PBDIT Margin (%), as of Mar 25, the value is 45.36. This value is within the healthy range. It has decreased from 51.49 (Mar 24) to 45.36, marking a decrease of 6.13.
• For PBIT Margin (%), as of Mar 25, the value is 43.39. This value exceeds the healthy maximum of 20. It has decreased from 48.38 (Mar 24) to 43.39, marking a decrease of 4.99.
• For PBT Margin (%), as of Mar 25, the value is 41.69. This value is within the healthy range. It has decreased from 46.59 (Mar 24) to 41.69, marking a decrease of 4.90.
• For Net Profit Margin (%), as of Mar 25, the value is 31.31. This value exceeds the healthy maximum of 10. It has decreased from 34.95 (Mar 24) to 31.31, marking a decrease of 3.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.70. This value is below the healthy minimum of 15. It has increased from 13.72 (Mar 24) to 14.70, marking an increase of 0.98.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.67. This value is within the healthy range. It has increased from 18.74 (Mar 24) to 19.67, marking an increase of 0.93.
• For Return On Assets (%), as of Mar 25, the value is 12.06. This value is within the healthy range. It has increased from 10.73 (Mar 24) to 12.06, marking an increase of 1.33.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.33 (Mar 24) to 0.40, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 5.24. This value exceeds the healthy maximum of 3. It has increased from 4.00 (Mar 24) to 5.24, marking an increase of 1.24.
• For Quick Ratio (X), as of Mar 25, the value is 4.09. This value exceeds the healthy maximum of 2. It has increased from 3.24 (Mar 24) to 4.09, marking an increase of 0.85.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 4. It has increased from 0.78 (Mar 24) to 1.20, marking an increase of 0.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.86 (Mar 24) to 0.00, marking a decrease of 13.86.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.73 (Mar 24) to 0.00, marking a decrease of 12.73.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.14 (Mar 24) to 0.00, marking a decrease of 86.14.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 87.27 (Mar 24) to 0.00, marking a decrease of 87.27.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 26.60. This value is within the healthy range. It has decreased from 28.69 (Mar 24) to 26.60, marking a decrease of 2.09.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.36. This value is within the healthy range. It has decreased from 20.47 (Mar 24) to 19.36, marking a decrease of 1.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,339.56. It has decreased from 13,170.79 (Mar 24) to 9,339.56, marking a decrease of 3,831.23.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.18. This value exceeds the healthy maximum of 3. It has decreased from 25.34 (Mar 24) to 13.18, marking a decrease of 12.16.
• For EV / EBITDA (X), as of Mar 25, the value is 29.06. This value exceeds the healthy maximum of 15. It has decreased from 49.21 (Mar 24) to 29.06, marking a decrease of 20.15.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.36. This value exceeds the healthy maximum of 3. It has decreased from 26.09 (Mar 24) to 13.36, marking a decrease of 12.73.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 86.13 (Mar 24) to 0.00, marking a decrease of 86.13.
• For Price / BV (X), as of Mar 25, the value is 6.28. This value exceeds the healthy maximum of 3. It has decreased from 10.24 (Mar 24) to 6.28, marking a decrease of 3.96.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.36. This value exceeds the healthy maximum of 3. It has decreased from 26.09 (Mar 24) to 13.36, marking a decrease of 12.73.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness